Company page
Regenxbio Inc.
Regenxbio Inc. is a public company traded under the ticker RGNX in the American market. The company has a market capitalization of approximately $403.24 million. Regenxbio focuses on developing gene therapies for various diseases, leveraging its proprietary AAV gene delivery platform.
- Ticker
- RGNX:NASDAQ
- Asset type
- Stock
- Market cap
- $403.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD